{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,19]],"date-time":"2026-05-19T13:10:02Z","timestamp":1779196202992,"version":"3.51.4"},"reference-count":57,"publisher":"Portland Press Ltd.","issue":"6","license":[{"start":{"date-parts":[[2026,4,21]],"date-time":"2026-04-21T00:00:00Z","timestamp":1776729600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/2.0\/"}],"funder":[{"name":"HHS | National Institutes of Health","award":["P01 HL146373"],"award-info":[{"award-number":["P01 HL146373"]}]},{"DOI":"10.13039\/100000968","name":"American Heart Association","doi-asserted-by":"crossref","award":["25POST1357254\/2025"],"award-info":[{"award-number":["25POST1357254\/2025"]}],"id":[{"id":"10.13039\/100000968","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["portlandpress.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2026,6,10]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Premorbid hypercoagulability causes obstetric complications; therefore, anticoagulation from the preconception period and throughout pregnancy may be beneficial in cases of bad obstetric history (BOH). The aim of the study is to test this hypothesis; 115 patients with BOH and 38 healthy women without prior obstetric complications were examined. Patients with antiphospholipid syndrome were excluded, and the groups were matched based on the frequency of congenital thrombophilia. Hemostasis was assessed before and during pregnancy using the thrombodynamics assay and routine coagulation tests. Platelet function was characterized using a blood clot contraction assay and flow cytometry. All patients with BOH received enoxaparin (low molecular weight heparin (LMWH)) starting from the preconception period and aspirin after the tenth week of pregnancy. Doses were adjusted based on dynamic laboratory monitoring. In women with BOH, premorbid hypercoagulability was associated with platelet dysfunction due to chronic activation and exhaustion. With enoxaparin and aspirin treatment before and during pregnancy, hemostasis and platelet function improved progressively. By the second trimester, these parameters were comparable to normal levels. In patients with BOH receiving enoxaparin and aspirin, pregnancy outcomes were significantly more favorable compared with previous pregnancies. No hemorrhagic complications were observed. For women with BOH, the early and controlled use of LMWH starting from the preconception period, along with aspirin from the 10th through the 34th week of pregnancy, improves hemostasis, prevents obstetric complications, and significantly increases the likelihood of a favorable pregnancy outcome. These results were achieved through dynamic laboratory monitoring using novel hemostatic assays and platelet contractility as biomarkers.<\/jats:p>","DOI":"10.1042\/cs20260246","type":"journal-article","created":{"date-parts":[[2026,4,21]],"date-time":"2026-04-21T14:50:36Z","timestamp":1776783036000},"page":"925-941","update-policy":"https:\/\/doi.org\/10.1042\/crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Early pregravid correction of hemostasis assessed by novel biomarkers improves the outcomes of pregnancies in women with bad obstetric history"],"prefix":"10.1042","volume":"140","author":[{"given":"Svetlana\u00a0I.","family":"Safiullina","sequence":"first","affiliation":[{"name":"1Institute of Fundamental Medicine and Biology, Kazan Federal University, Kazan, Russian Federation"},{"name":"2Medical Center \u2018Aibolit,\u2019 Kazan, Russian Federation"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4950-3691","authenticated-orcid":false,"given":"Natalia\u00a0G.","family":"Evtugina","sequence":"additional","affiliation":[{"name":"1Institute of Fundamental Medicine and Biology, Kazan Federal University, Kazan, Russian Federation"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8790-1818","authenticated-orcid":false,"given":"Alina\u00a0D.","family":"Peshkova","sequence":"additional","affiliation":[{"name":"3Department of Pharmacology, University of Pennsylvania School of Medicine, Philadelphia, PA, U.S.A."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9628-257X","authenticated-orcid":false,"given":"John\u00a0W.","family":"Weisel","sequence":"additional","affiliation":[{"name":"4Department of Cell and Developmental Biology, University of Pennsylvania School of Medicine, Philadelphia, PA, U.S.A."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0643-1496","authenticated-orcid":false,"given":"Rustem\u00a0I.","family":"Litvinov","sequence":"additional","affiliation":[{"name":"4Department of Cell and Developmental Biology, University of Pennsylvania School of Medicine, Philadelphia, PA, U.S.A."}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"288","published-online":{"date-parts":[[2026,5,15]]},"reference":[{"key":"2026051908315894100_B1","doi-asserted-by":"publisher","first-page":"934","DOI":"10.1016\/j.fertnstert.2023.08.954","article-title":"The prevalence of sporadic and recurrent pregnancy loss","volume":"120","author":"Genovese","year":"2023","journal-title":"Fertil. Steril."},{"key":"2026051908315894100_B2","doi-asserted-by":"publisher","first-page":"1658","DOI":"10.1016\/S0140-6736(21)00682-6","article-title":"Miscarriage matters: the epidemiological, physical, psychological, and economic costs of early pregnancy loss","volume":"397","author":"Quenby","year":"2021","journal-title":"Lancet North Am. Ed."},{"key":"2026051908315894100_B3","first-page":"1409","article-title":"Recurrent miscarriage","volume":"2015","author":"Duckitt","year":"2015","journal-title":"BMJ Clin. Evid."},{"key":"2026051908315894100_B4","doi-asserted-by":"publisher","first-page":"1103","DOI":"10.1016\/j.fertnstert.2012.06.048","article-title":"Evaluation and treatment of recurrent pregnancy loss: a committee opinion","volume":"98","author":"Practice Committee of the American Society for Reproductive Medicine","year":"2012","journal-title":"Fertil. Steril."},{"key":"2026051908315894100_B5","doi-asserted-by":"publisher","first-page":"5744","DOI":"10.1038\/s41467-024-49993-5","article-title":"Common and rare genetic variants predisposing females to unexplained recurrent pregnancy loss","volume":"15","author":"Sonehara","year":"2024","journal-title":"Nat. Commun."},{"key":"2026051908315894100_B6","doi-asserted-by":"publisher","first-page":"4074","DOI":"10.3390\/jcm12124074","article-title":"Recurrent pregnancy loss etiology, risk factors, diagnosis, and management. Fresh look into a full box","volume":"12","author":"Turesheva","year":"2023","journal-title":"J. Clin. Med."},{"key":"2026051908315894100_B7","doi-asserted-by":"publisher","first-page":"1994","DOI":"10.1055\/s-0039-1696972","article-title":"Premorbid hemostasis in women with a history of pregnancy loss","volume":"119","author":"Peshkova","year":"2019","journal-title":"Thromb. Haemost."},{"key":"2026051908315894100_B8","doi-asserted-by":"publisher","first-page":"1096","DOI":"10.1055\/s-0038-1656119","article-title":"Prospective evaluation of the prevalence of haemostasis abnormalities in unexplained primary early recurrent miscarriages","volume":"77","author":"Gris","year":"1997","journal-title":"Thromb. Haemost."},{"key":"2026051908315894100_B9","doi-asserted-by":"publisher","first-page":"813343","DOI":"10.3389\/fmed.2022.813343","article-title":"A review of roles of uterine artery Doppler in pregnancy complications","volume":"9","author":"Tian","year":"2022","journal-title":"Front. Med. (Lausanne)"},{"key":"2026051908315894100_B10","doi-asserted-by":"publisher","first-page":"S829","DOI":"10.1016\/j.ajog.2017.11.565","article-title":"The role of aspirin, heparin, and other interventions in the prevention and treatment of fetal growth restriction","volume":"218","author":"Groom","year":"2018","journal-title":"Am. J. Obstet. Gynecol."},{"key":"2026051908315894100_B11","doi-asserted-by":"publisher","first-page":"1414","DOI":"10.1007\/s43032-021-00678-0","article-title":"Low molecular weight heparins (LMWH) and implications along pregnancy: a focus on the placenta","volume":"29","author":"Zullino","year":"2022","journal-title":"Reproduct. Sci."},{"key":"2026051908315894100_B12","doi-asserted-by":"publisher","first-page":"e10956","DOI":"10.7759\/cureus.10956","article-title":"Role of low molecular weight heparin in the management of unexplained recurrent pregnancy loss: a review of literature","volume":"12","author":"Awolumate","year":"2020","journal-title":"Cureus"},{"key":"2026051908315894100_B13","article-title":"Reducing the risk of venous thromboembolism during pregnancy and the puerperium","author":"Royal College of Obstetricians and Gynaecologists","year":"2015"},{"key":"2026051908315894100_B14","doi-asserted-by":"publisher","first-page":"CD002859","DOI":"10.1002\/14651858.CD002859.pub2","article-title":"Prevention of recurrent miscarriage for women with antiphospholipid antibody or lupus anticoagulant","volume":"2012","author":"Empson","year":"2005","journal-title":"Cochrane Database Syst. Rev."},{"key":"2026051908315894100_B15","doi-asserted-by":"publisher","first-page":"267","DOI":"10.4103\/0366-6999.198934","article-title":"Antiphospholipid antibody titers and clinical outcomes in patients with recurrent miscarriage and antiphospholipid antibody syndrome","volume":"130","author":"Song","year":"2017","journal-title":"Chin. Med. J. (Engl.)"},{"key":"2026051908315894100_B16","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1177\/0300060520945558","article-title":"Role of low-molecular-weight heparin in altering uterine artery blood flow in recurrent spontaneous abortion: a prospective study","volume":"48","author":"Zhang","year":"2020","journal-title":"J. Int. Med. Res."},{"key":"2026051908315894100_B17","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1097\/BOR.0000000000000932","article-title":"Antiphospholipid syndrome management: a 2023 update and practical algorithm-based approach","volume":"35","author":"Ambati","year":"2023","journal-title":"Curr. Opin. Rheumatol."},{"key":"2026051908315894100_B18","doi-asserted-by":"publisher","first-page":"2111","DOI":"10.1007\/s10067-020-05183-4","article-title":"Management of antiphospholipid syndrome","volume":"39","author":"Rahman","year":"2020","journal-title":"Clin. Rheumatol."},{"key":"2026051908315894100_B19","doi-asserted-by":"publisher","first-page":"287.e1","DOI":"10.1016\/j.ajog.2017.11.561","article-title":"Aspirin for the prevention of preterm and term preeclampsia: systematic review and metaanalysis","volume":"218","author":"Roberge","year":"2018","journal-title":"Am. J. Obstet. Gynecol."},{"key":"2026051908315894100_B20","doi-asserted-by":"publisher","first-page":"2344079","DOI":"10.1080\/0167482X.2024.2344079","article-title":"Impact of low-dose aspirin exposure on obstetrical outcomes: a meta-analysis","volume":"45","author":"Lin","year":"2024","journal-title":"J. Psychosom. Obstet. Gynecol."},{"key":"2026051908315894100_B21","doi-asserted-by":"publisher","first-page":"CD004659","DOI":"10.1002\/14651858.CD004659.pub3","article-title":"Antiplatelet agents for preventing pre-eclampsia and its complications","volume":"2019","author":"Duley","year":"2019","journal-title":"Cochrane Database Syst. Rev."},{"key":"2026051908315894100_B22","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1016\/j.ejogrb.2021.05.017","article-title":"Aspirin for preventing adverse outcomes in low risk nulliparous women with singleton pregnancies: a systematic review and meta-analysis","volume":"262","author":"Man","year":"2021","journal-title":"Eur. J. Obstet. Gynecol. Reproduct. Biol."},{"key":"2026051908315894100_B23","doi-asserted-by":"publisher","first-page":"10732","DOI":"10.3390\/ijms221910732","article-title":"Changes in maternal platelet physiology during gestation and their interaction with trophoblasts","volume":"22","author":"Forstner","year":"2021","journal-title":"Int. J. Mol. Sci."},{"key":"2026051908315894100_B24","doi-asserted-by":"publisher","first-page":"549","DOI":"10.1053\/plac.2002.0923","article-title":"Vascular endothelial growth factor is a chemoattractant for trophoblast cells","volume":"24","author":"Lash","year":"2003","journal-title":"Placenta"},{"key":"2026051908315894100_B25","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1182\/blood-2015-05-647560","article-title":"Kinetics and mechanics of clot contraction are governed by the molecular and cellular composition of the blood","volume":"127","author":"Tutwiler","year":"2016","journal-title":"Blood"},{"key":"2026051908315894100_B26","doi-asserted-by":"publisher","first-page":"282","DOI":"10.1016\/j.talanta.2017.12.055","article-title":"Thrombodynamics, a new global coagulation test: measurement of heparin efficiency","volume":"180","author":"Sinauridze","year":"2018","journal-title":"Talanta"},{"key":"2026051908315894100_B27","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1016\/j.thromres.2020.01.012","article-title":"Hyper-coagulability in obese patients accurately identified by combinations of global coagulation assay parameters","volume":"187","author":"Bertaggia Calderara","year":"2020","journal-title":"Thromb. Res."},{"key":"2026051908315894100_B28","doi-asserted-by":"publisher","first-page":"e0199900","DOI":"10.1371\/journal.pone.0199900","article-title":"Thrombodynamics\u2014a new global hemostasis assay for heparin monitoring in patients under the anticoagulant treatment","volume":"13","author":"Balandina","year":"2018","journal-title":"PloS One"},{"key":"2026051908315894100_B29","doi-asserted-by":"publisher","first-page":"100023","DOI":"10.1016\/j.rpth.2022.100023","article-title":"Blood clot contraction: mechanisms, pathophysiology, and disease","volume":"7","author":"Litvinov","year":"2023","journal-title":"Res. Pract. Thromb. Haemost."},{"key":"2026051908315894100_B30","doi-asserted-by":"publisher","first-page":"19975","DOI":"10.1038\/s41598-022-24098-5","article-title":"A familial case of MYH9 gene mutation associated with multiple functional and structural platelet abnormalities","volume":"12","author":"Safiullina","year":"2022","journal-title":"Sci. Rep."},{"key":"2026051908315894100_B31","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1038\/nmat2903","article-title":"Mechanics and contraction dynamics of single platelets and implications for clot stiffening","volume":"10","author":"Lam","year":"2011","journal-title":"Nat. Mater."},{"key":"2026051908315894100_B32","doi-asserted-by":"publisher","first-page":"16290","DOI":"10.1038\/s41598-021-95397-6","article-title":"Altered platelet and coagulation function in moderate-to-severe COVID-19","volume":"11","author":"Litvinov","year":"2021","journal-title":"Sci. Rep."},{"key":"2026051908315894100_B33","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1161\/ATVBAHA.116.308622","article-title":"Contraction of blood clots is impaired in acute ischemic stroke","volume":"37","author":"Tutwiler","year":"2017","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"2026051908315894100_B34","doi-asserted-by":"publisher","first-page":"9434","DOI":"10.3390\/ijms21249434","article-title":"Accelerated spatial fibrin growth and impaired contraction of blood clots in patients with rheumatoid arthritis","volume":"21","author":"Peshkova","year":"2020","journal-title":"Int. J. Mol. Sci."},{"key":"2026051908315894100_B35","doi-asserted-by":"publisher","first-page":"7336","DOI":"10.3390\/ijms23137336","article-title":"Chronic immune platelet activation is followed by platelet refractoriness and impaired contractility","volume":"23","author":"Andrianova","year":"2022","journal-title":"Int. J. Mol. Sci."},{"key":"2026051908315894100_B36","doi-asserted-by":"publisher","first-page":"101355","DOI":"10.1016\/j.jacbts.2025.101355","article-title":"Impaired secondary platelet response in chronic kidney disease as a consequence of prior platelet activation","volume":"10","author":"Baaten","year":"2025","journal-title":"JACC Basic Transl. Sci."},{"key":"2026051908315894100_B37","doi-asserted-by":"publisher","first-page":"062","DOI":"10.1055\/a-2516-7384","article-title":"Heparin and direct oral anticoagulants have different effects on the phases of activation and spatial spread of blood coagulation","volume":"126","author":"Ataullakhanov","year":"2026","journal-title":"Thromb. Haemost."},{"key":"2026051908315894100_B38","doi-asserted-by":"publisher","first-page":"e76","DOI":"10.1016\/j.thromres.2009.09.013","article-title":"Platelet activation and endogenous thrombin potential in pre-eclampsia","volume":"125","author":"Macey","year":"2010","journal-title":"Thromb. Res."},{"key":"2026051908315894100_B39","doi-asserted-by":"publisher","first-page":"461","DOI":"10.1016\/S0002-9378(97)70516-7","article-title":"Extensive platelet activation in preeclampsia compared with normal pregnancy: enhanced expression of cell adhesion molecules","volume":"176","author":"Konijnenberg","year":"1997","journal-title":"Am. J. Obstet. Gynecol."},{"key":"2026051908315894100_B40","doi-asserted-by":"publisher","first-page":"437","DOI":"10.1016\/j.ajog.2019.05.044","article-title":"Placental bed research: I. The placental bed: from spiral arteries remodeling to the great obstetrical syndromes","volume":"221","author":"Brosens","year":"2019","journal-title":"Am. J. Obstet. Gynecol."},{"key":"2026051908315894100_B41","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1007\/s00795-019-00220-x","article-title":"Heparin prevents oxidative stress-induced apoptosis in human decidualized endometrial stromal cells","volume":"52","author":"Tamaru","year":"2019","journal-title":"Med. Mol. Morphol."},{"key":"2026051908315894100_B42","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1016\/j.jdmv.2020.03.002","article-title":"Anticoagulant activity and pleiotropic effects of heparin","volume":"45","author":"Bal dit Sollier","year":"2020","journal-title":"J. M\u00e9d. Vasc."},{"key":"2026051908315894100_B43","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.tjog.2020.11.001","article-title":"The role of low molecular weight heparin on recurrent pregnancy loss: a systematic review and meta-analysis","volume":"60","author":"Jiang","year":"2021","journal-title":"Taiwan J. Obstet. Gynecol."},{"key":"2026051908315894100_B44","doi-asserted-by":"publisher","first-page":"1819","DOI":"10.1007\/s40265-017-0823-0","article-title":"Aspirin for prevention of preeclampsia","volume":"77","author":"Atallah","year":"2017","journal-title":"Drugs"},{"key":"2026051908315894100_B45","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1007\/s00109-019-01866-x","article-title":"Platelet-derived factors impair placental chorionic gonadotropin beta-subunit synthesis","volume":"98","author":"Forstner","year":"2020","journal-title":"J. Mol. Med."},{"key":"2026051908315894100_B46","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1097\/AOG.0000000000002706","article-title":"American College of Obstetricians and Gynecologists' Committee on Practice Bulletins\u2014Obstetrics. ACOG Practice Bulletin No. 196: Thromboembolism in Pregnancy","volume":"132","year":"2018","journal-title":"Obstet. Gynecol."},{"key":"2026051908315894100_B47","first-page":"1","article-title":"ESHRE guideline: recurrent pregnancy loss","volume":"2018","author":"Bender Atik","year":"2018","journal-title":"Hum. Reprod. Open"},{"key":"2026051908315894100_B48","doi-asserted-by":"publisher","first-page":"298","DOI":"10.1016\/j.placenta.2006.04.001","article-title":"Low-molecular weight heparin induces in vitro trophoblast invasiveness: role of matrix metalloproteinases and tissue inhibitors","volume":"28","author":"Di Simone","year":"2007","journal-title":"Placenta"},{"key":"2026051908315894100_B49","doi-asserted-by":"publisher","first-page":"797","DOI":"10.1111\/1471-0528.13421","article-title":"Does low-molecular-weight heparin influence fetal growth or uterine and umbilical arterial Doppler in women with a history of early-onset uteroplacental insufficiency and an inheritable thrombophilia? Secondary randomised controlled trial results","volume":"123","author":"Abheiden","year":"2016","journal-title":"BJOG"},{"key":"2026051908315894100_B50","doi-asserted-by":"publisher","first-page":"1053","DOI":"10.1097\/AOG.0000000000001673","article-title":"Enoxaparin and aspirin compared with aspirin alone to prevent placenta-mediated pregnancy complications","volume":"128","author":"Haddad","year":"2016","journal-title":"Obstet. Gynecol."},{"key":"2026051908315894100_B51","doi-asserted-by":"publisher","first-page":"14168","DOI":"10.1038\/s41598-024-62949-5","article-title":"Low-molecular-weight heparin in the prevention of unexplained recurrent miscarriage: a systematic review and meta-analysis","volume":"14","author":"Scarrone","year":"2024","journal-title":"Sci. Rep."},{"key":"2026051908315894100_B52","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1016\/S0140-6736(23)00693-1","article-title":"Heparin for women with recurrent miscarriage and inherited thrombophilia (ALIFE2): an international open-label, randomised controlled trial","volume":"402","author":"Quenby","year":"2023","journal-title":"Lancet North Am. Ed."},{"key":"2026051908315894100_B53","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1016\/S0140-6736(23)02342-5","article-title":"Concerns about the ALIFE2 trial","volume":"403","author":"Tang","year":"2024","journal-title":"Lancet North Am. Ed."},{"key":"2026051908315894100_B54","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1016\/S0140-6736(23)02337-1","article-title":"Concerns about the ALIFE2 trial","volume":"403","author":"Fan","year":"2024","journal-title":"Lancet North Am. Ed."},{"key":"2026051908315894100_B55","doi-asserted-by":"publisher","first-page":"1139","DOI":"10.1097\/01.AOG.0000437385.88715.4a","article-title":"ACOG Committee Opinion No 579: Definition of term pregnancy","volume":"122","year":"2013","journal-title":"Obstet. Gynecol."},{"key":"2026051908315894100_B56","doi-asserted-by":"publisher","first-page":"246","DOI":"10.1016\/S0140-6736(23)02338-3","article-title":"Concerns about the ALIFE2 trial","volume":"403","author":"Grandone","year":"2024","journal-title":"Lancet North Am. Ed."},{"key":"2026051908315894100_B57","doi-asserted-by":"publisher","first-page":"721","DOI":"10.1097\/OGX.0000000000000505","article-title":"The safety of low-molecular-weight heparin during and after pregnancy","volume":"72","author":"Lu","year":"2017","journal-title":"Obstet. Gynecol. Surv."}],"container-title":["Clinical Science"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/portlandpress.com\/clinsci\/article-pdf\/140\/6\/925\/987121\/cs-2026-0246.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/portlandpress.com\/clinsci\/article-pdf\/140\/6\/925\/987121\/cs-2026-0246.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,19]],"date-time":"2026-05-19T12:32:03Z","timestamp":1779193923000},"score":1,"resource":{"primary":{"URL":"https:\/\/portlandpress.com\/clinsci\/article\/140\/6\/925\/237451\/Early-pregravid-correction-of-hemostasis-assessed"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,15]]},"references-count":57,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2026,6,10]]}},"URL":"https:\/\/doi.org\/10.1042\/cs20260246","relation":{},"ISSN":["0143-5221","1470-8736"],"issn-type":[{"value":"0143-5221","type":"print"},{"value":"1470-8736","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2026,6]]},"published":{"date-parts":[[2026,5,15]]}}}